792
U N I T 9
Endocrine System
24. Kaplowitz PB, Oberfield SE. Reexamination of the age limit
for defining when puberty is precocious in girls in the United
States: implications for evaluation and treatment.
Pediatrics.
1999;104:936–941.
25. Cooper DS, Greenspan FS, Ladenson PW. The thyroid gland. In:
Gardner DG, Shoback D, eds.
Basic and Clinical Endocrinology
.
9th ed. New York, NY: Lange Medical Books/McGraw-Hill
Medical; 2011:163–226.
26. Guyton AC, Hall JE.
Medical Physiology
. 12th ed. Philadelphia,
PA: Elsevier Saunders; 2012:907–920.
27. Koulouri O, Gurnell M. Interpretation of thyroid function tests.
Clin Med.
2013;13:282–286.
28. Pearce EN, Farwell AP, Braverman LE. Thyroiditis.
N Engl J
Med.
2003;348:2646–2655.
29. Devdhar M, Ousman YH, Burman KD. Hypothyroidism.
Endocrinol Metab Clin North Am.
2007;36:595–615.
30. Fatourechl V. Subclinical hypothyroidism: an update for primary
care physicians.
Mayo Clin Proc.
2009;84(1):65–71.
31. Wartofsky L. Myxedema coma.
Endocrinol Metab Clin North
Am.
2006;35:687–698.
32. Cooper DS. Hyperthyroidism.
Lancet.
2003;362:459–468.
33. Pearce EN, Hennessey JV, McDermott MT. New American
Thyroid Association and American Association of Clinical
Endocrinologists guidelines for thyrotoxicosis and other forms of
hyperthyroidism: significant progress for the clinician and a guide
to future research.
Thyroid.
2011;21:573–576.
34. McKenna TJ. Graves’ disease.
Lancet.
2001;357:1793–1796.
35. Brent GA. Graves’ disease.
N Engl J Med.
2008;358(24):2594–2605.
36. Bartalena L, Tanda ML. Graves’ ophthalmopathy.
N Engl J Med.
2009;360(10):994–1001.
37. Bahn R. Pathophysiology of Graves’ ophthalmopathy: the cycle
of disease.
J Clin Endocrinol Metab.
2003;88:1939–1946.
38. Matfin G. Endocrine and metabolic emergencies: thyroid storm.
Ther Adv Endocrinol Metab.
2010;3:139–145.
39. Aron DC, Findling JW, Tyrrell JB, et al. Glucocorticoids and
adrenal androgens. In: Gardner DG, Shoback D, eds.
Basic and
Clinical Endocrinology
. 9th ed. New York, NY: Lange Medical
Books/McGraw-Hill Medical; 2011:285–328.
40. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s
syndrome.
Lancet.
2006;367:1605–1617.
41. Pivonello R, Cristina M, DeMartino CM, et al. Cushing’s
syndrome.
Endocrinol Metab Clin North Am.
2008;37:
135–149.
42. White PC, Bachega T. Congenital adrenal hyperplasia.
Semin
Reprod Med.
2012;30:400.
43. Boos CJ, Rumsby G, Matfin G. Multiple tumors associated with
late onset congenital hyperplasia due to aberrant splicing of
adrenal 21-hydroxylase gene.
Endocr Pract.
2002;8:470–473.
44. Arlt W, Allolio B. Adrenal insufficiency.
Lancet.
2003;361:1881–1893.
45. Bouillon R. Acute adrenal insufficiency.
Endocrinol Metab Clin
North Am.
2006;35:767–775.
46. Bornstein SR. Predisposing factors for adrenal insufficiency.
N Engl J Med.
2009;360(22):2328–2339.
47. Raff H, Findling JW. A physiological approach to the
diagnosis of Cushing’s syndrome.
Ann Intern Med.
2003;138:980–991.
48. Nieman LK, Ilias I. Evaluation and treatment of Cushing’s
syndrome.
Am J Med.
2005;118:1340–1346.
49. Gopan T, Remer E, Hamrahian AH. Evaluating and managing
adrenal incidentalomas.
Cleve Clin J Med.
2006;73:561–568.
50. Grumbach MM, Biller BMK, Braunstein GD, et al. Management
of the clinically inapparent adrenal mass (“incidentaloma”).
Ann
Intern Med.
2003;138:424–429.
Porth Essentials Resources
Explore these additional resources to enhance learning
for this chapter:
•
NCLEX-Style Questions and Other Resources
on
,
•
Study Guide for Essentials of Pathophysiology
•
Concepts in Action Animations
•
Adaptive Learning | Powered by PrepU,
prepu
